Positron-Emission Tomography: Clinical Trials

5 trials for Positron-Emission Tomography, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Unknown 2
Phase 21Unknown 1

Follow Positron-Emission Tomography: new trials by email Literature Review of Positron-Emission Tomography trials Research Report on Positron-Emission Tomography

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies
68Ga-FAP-CHX - Tumor, Positron-Emission Tomography
Phase 1 / Phase 2UnknownFirst Affiliated Hospital of Fujian Medical University502022-05-012023-09-21
68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases
68Ga-NOTA Evans Blue - Positron-Emission Tomography
Phase 1UnknownFirst Affiliated Hospital of Fujian Medical University802021-04-252023-09-21
⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma
⁸⁹Zr-Df-IAB22M2C Infusion - Positron-Emission Tomography, Immunomodulation
Phase 1CompletedImaginAb, Inc.152017-06-192018-09-18
Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers
F-18 FEDAA1106 (BAY85-8101) - Positron-Emission Tomography, Multiple Sclerosis
Phase 1CompletedBayer162009-01-012014-04-02
Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers
F-18 FEDAA1106 (BAY85-8101) - Positron-Emission Tomography, Alzheimer's Disease
Phase 1CompletedBayer252007-06-012015-01-08

Narrower conditions

Neuroinflammatory Diseases (2)  ·  Alzheimer Disease (1)  ·  Hodgkin Disease (1)  ·  Multiple Sclerosis (1)  ·  Neoplasms (1)

Broader conditions

Immune System Diseases (2)  ·  Inflammation (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)

Interventions

68Ga-FAPI (1)  ·  Fluorodeoxyglucose F18 (1)

Sponsors

Bayer (2)  ·  First Affiliated Hospital of Fujian Medical University (2)  ·  ImaginAb, Inc. (1)

Countries

China (2)  ·  Sweden (2)  ·  Australia (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Weibing Miao, MD (1)

Results publications

PMID 23618062, PMID 34413145

NIH funding

2008 (1)